CAMZYOS is a Oral Capsule, Gelatin Coated in the Cellular Therapy category. It is labeled and distributed by Myokardia, Inc.. The primary component is Mavacamten.
| Product ID | 73625-112_175808e7-ba8b-49b6-bc26-3de9d98ecfd4 |
| NDC | 73625-112 |
| Product Type | Cellular Therapy |
| Proprietary Name | CAMZYOS |
| Generic Name | Mavacamten |
| Dosage Form | Capsule, Gelatin Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2022-04-28 |
| Marketing Category | NDA / |
| Application Number | NDA214998 |
| Labeler Name | Myokardia, Inc. |
| Substance Name | MAVACAMTEN |
| Active Ingredient Strength | 5 mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-04-28 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 73625-111 | CAMZYOS | mavacamten |
| 73625-112 | CAMZYOS | mavacamten |
| 73625-113 | CAMZYOS | mavacamten |
| 73625-114 | CAMZYOS | mavacamten |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() CAMZYOS 98478203 not registered Live/Pending |
MyoKardia, Inc. 2024-04-01 |
![]() CAMZYOS 97539194 not registered Live/Pending |
MyoKardia, Inc. 2022-08-08 |
![]() CAMZYOS 90463748 not registered Live/Pending |
MyoKardia, Inc. 2021-01-13 |
![]() CAMZYOS 88693134 not registered Live/Pending |
MyoKardia, Inc. 2019-11-14 |